NASDAQ: KURA · Biotechnology
Over the past week, Kura Oncology (KURA) drew 14 mentions across Reddit, X and news, and the read is an Adanos Hold. The crowd averages 52% bullish but is sharply divided: X runs 88% bullish while Reddit sits at just 0%. Wall Street is more constructive, with 14 of 15 analysts rating KURA a buy.
There is little buzz around KURA this week and little agreement on direction, which is why it reads as a Hold.
Wall Street’s 93% buy share sits next to a crowd that ranges from Reddit at 0% to X at 88%. No other tracker puts the two side by side.
15 analysts have weighed in: a Strong Buy consensus: 14 buy calls against 0 sell, with an average 12-month price target of $32.00.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits right on the neutral line, momentum is cooling and the 3 sources disagree sharply, so the read is Hold rather than a clear buy or sell.
Analysts sit 41 points above the crowd average of 52%, the professionals are more constructive than retail. The split is inside the crowd: X reads 88% bullish while Reddit sits at 0%, a 88-point spread that single-source trackers miss.
Over the 30-day window, Kura Oncology (KURA) buzz held subdued around 31.1 while the price drifted up 42.8% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 2.2M shares. Over the last 7 trading days, KURA held roughly flat. Buzz activity in the recent week averaged 34.1 and was relatively stable, swinging between 27.3 and 45.8. Recent volume is running below the 30-day average, pointing to quieter participation. Daily crowd sentiment leaned bullish on 14 of the 18 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for KURA and 2001+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live KURA sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Sep 04, 2026.
| Adanos signal | Hold |
|---|---|
| Analyst consensus | Strong Buy (14 / 1 / 0) |
| Crowd bullish (7d) | 52% |
| Avg price target | $32.00 |
| Most bullish source | X, 88% |
| Most bearish source | Reddit, 0% |
| Sentiment spread | 88 pts |
| Mentions (7d) | 14 |
| Market cap | $1.17B |
| EPS · Beta | -$3.37 · 0.4 |
| Revenue (TTM) | $77.2M · 0% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Kura Oncology (KURA) currently carries an Adanos hold signal with 53/100 conviction. The current cross-source average reads 52% bullish across 3 active sources. Those sources contribute 14 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Kura Oncology (KURA) is fairly quiet with 0 mentions over the last 7 days; the 30-day context spans 7 tracked subreddits. The 7-day tone is 0% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads split on Kura Oncology (KURA), averaging 52% bullish across 3 tracked sources over the last 7 days. The two ends of the range are X at 88% bullish and Reddit at 0%, a 88-point spread. On the professional side, 14 of 15 analysts rate KURA a buy.
Of the 15 analysts covering Kura Oncology (KURA), 14 rate it a buy, 1 a hold and 0 a sell, for a strong buy consensus. The average price target is $32.00. That puts the street ahead of the crowd, which averages 52% bullish.
Kura Oncology (KURA)'s cross-source average is mixed at 52% bullish. Source readings are split: 2 sources lean bullish and 1 source leans bearish. X reads 88% bullish, News reads 67% bullish and reddit coverage is the most negative at 0% bullish. The combined signal points to broad mixed pressure with 53/100 conviction.
The cross-source average is mixed for Kura Oncology (KURA) at 52% bullish. Source readings are split: 2 sources lean bullish and 1 source leans bearish. The most bearish reading is reddit at 0% bullish. 3-day activity momentum is falling across News. The hold signal carries 53/100 conviction.
X is the dominant discussion channel with 8 mentions (57% of total volume). News contributes 6 mentions. The cross-source average is mixed at 52% bullish. Source readings are split: 2 sources lean bullish and 1 source leans bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. KURA's hold signal at 53/100 conviction reflects a mixed cross-source average at 52% bullish. Source readings are split: 2 sources lean bullish and 1 source leans bearish. It is a research shortcut, not financial advice.
The KURA sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Hold signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key